GlassScriptPhysician profile
Vasant Bharat Patel
NPI 1568418838
$4,167.23
in general payments reported to CMS, 2019-2025
34 companies · $416 in 2025
The $416 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $130 · 2021: $963 · 2022: $774 · 2023: $1,100 · 2024: $351 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,865 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,865.27 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $775.86 | 2021-2025 | Impella |
| Abbott Laboratories | $513.53 | 2021-2023 | Diamondback Peripheral, Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Coronary |
| Edwards Lifesciences Corporation | $275.65 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Astrazeneca Pharmaceuticals LP | $226.30 | 2020-2021 | |
| Medtronic, INC. | $200.22 | 2021-2023 | Corevalve Evolut R |
| Novo Nordisk INC | $181.99 | 2024-2025 | Ozempic |
| Heartflow, INC. | $155.71 | 2025 | |
| Biotronik INC. | $143.90 | 2024 | Acticor 7 Vr-T Dx, Biomonitor |
| Inspire Medical Systems, INC. | $140.33 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $138.35 | 2021-2023 | |
| Actelion Pharmaceuticals US, INC. | $131.30 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $128.72 | 2019-2024 | Eliquis, Camzyos |
| Boston Scientific Corporation | $128.05 | 2019-2025 | Avvigo Guidance System, Varithena Administration Pack, Ekosonic |
| Genzyme Corporation | $125.00 | 2019 | |
| Inari Medical, INC. | $117.35 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.24 | 2023 | Jardiance |
| Stability Biologics, LLC | $104.67 | 2023 | |
| United Therapeutics Corporation | $100.00 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.74 | 2022-2023 | Lifevest |
| Merck Sharp & Dohme LLC | $55.33 | 2023-2024 | |
| Tactile Systems Technology INC | $48.76 | 2021-2023 | Flexitouch Plus, Entre Plus |
| Lexicon Pharmaceuticals, INC. | $46.77 | 2024 | |
| Sanofi-Aventis U.S. LLC | $38.37 | 2019 | |
| Kestra Medical Technology Services, INC. | $33.43 | 2024 | Assure Wcd |
| Cardiovascular Systems INC. | $33.31 | 2021 | |
| Cardiva Medical, INC. | $24.39 | 2021 | |
| Atricure, INC. | $20.11 | 2023 | |
| Terumo Medical Corporation | $18.75 | 2021 | |
| Davol INC. | $17.36 | 2025 | Avitene Ultrafoam |
| Cardinal Health 200 LLC | $16.55 | 2019 | |
| Amgen INC. | $15.49 | 2022 | |
| Medtronic Vascular, INC. | $11.49 | 2019 | |
| Janssen Pharmaceuticals, INC | $9.21 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vasant Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.